TriMas (NASDAQ:TRS) Stock Rating Lowered by Wall Street Zen

TriMas (NASDAQ:TRS) was downgraded by Wall Street Zen from a “buy” rating to a “hold” rating in a report issued on Saturday.

A number of other brokerages have also commented on TRS. BWS Financial restated a “buy” rating and issued a $45.00 target price on shares of TriMas in a research note on Friday. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a report on Monday. KeyCorp reduced their price objective on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating for the company in a report on Thursday, November 13th. Finally, Zacks Research upgraded shares of TriMas from a “hold” rating to a “strong-buy” rating in a research report on Friday, August 29th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus target price of $41.50.

TriMas Stock Performance

TRS stock opened at $33.48 on Friday. The firm has a 50 day moving average of $35.09 and a two-hundred day moving average of $33.49. TriMas has a 12 month low of $19.33 and a 12 month high of $40.34. The company has a market capitalization of $1.36 billion, a price-to-earnings ratio of 31.00 and a beta of 0.62. The company has a quick ratio of 1.42, a current ratio of 2.68 and a debt-to-equity ratio of 0.56.

TriMas (NASDAQ:TRS) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $0.61 earnings per share for the quarter, beating analysts’ consensus estimates of $0.57 by $0.04. The business had revenue of $269.26 million for the quarter, compared to the consensus estimate of $262.05 million. TriMas had a return on equity of 12.39% and a net margin of 4.35%.The firm’s revenue was up 17.4% compared to the same quarter last year. During the same period last year, the business earned $0.43 EPS. TriMas has set its FY 2025 guidance at 2.020-2.120 EPS. As a group, equities analysts anticipate that TriMas will post 1.69 EPS for the current fiscal year.

Insider Activity at TriMas

In other news, Director Jeffrey A. Fielkow purchased 2,000 shares of the business’s stock in a transaction on Tuesday, November 11th. The stock was purchased at an average price of $31.46 per share, for a total transaction of $62,920.00. Following the completion of the purchase, the director directly owned 17,653 shares in the company, valued at $555,363.38. The trade was a 12.78% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 14.20% of the company’s stock.

Hedge Funds Weigh In On TriMas

Hedge funds have recently bought and sold shares of the company. CIBC Bancorp USA Inc. bought a new stake in shares of TriMas during the 3rd quarter worth $1,595,000. Coldstream Capital Management Inc. acquired a new position in TriMas during the third quarter worth about $467,000. PharVision Advisers LLC bought a new position in shares of TriMas in the third quarter worth about $207,000. Dark Forest Capital Management LP boosted its stake in shares of TriMas by 598.5% in the 3rd quarter. Dark Forest Capital Management LP now owns 99,162 shares of the industrial products company’s stock valued at $3,832,000 after purchasing an additional 84,966 shares in the last quarter. Finally, Quarry LP acquired a new stake in shares of TriMas in the 3rd quarter valued at approximately $36,000. 99.42% of the stock is owned by institutional investors.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.